Literature DB >> 15201482

Injured brain endothelial cells release neurotoxic thrombin.

Paula Grammas1, Todd Ottman, Ulrich Reimann-Philipp, Jason Larabee, Paul H Weigel.   

Abstract

The multifunctional serine protease thrombin has been shown to be neurotoxic in vitro and in vivo and is demonstrable in the Alzheimer disease (AD) brain. We have documented that in AD the cerebral microvasculature is a source of inflammatory and neurotoxic proteins. The objective of this study was to determine if injured brain endothelial cells could be a source of neurotoxic thrombin. Brain endothelial cells were incubated with either sodium nitroprusside (SNP, 10 microM), inflammatory proteins (IL-1beta, IL-6, TNFalpha, LPS, IFNgamma) or the PKC inhibitor bisindolymaleimide (1 microM) for 24 h and conditioned media collected. Endothelial cell conditioned medium was incubated with purified apolipoprotein E4 (apoE4) for 24 h, and then analyzed for neurotoxic activity against primary cortical cultures and for apoE4 fragments by western blot. Endothelial cell conditioned medium collected after treatment with either SNP, inflammatory proteins, or the PKC inhibitor bisindolymaleimide, demonstrated a significant (p < 0.005) level of thrombin activity, the presence of apoE4 fragments, and was capable of evoking neuronal cell death. These data demonstrate that endothelial cell injury results in thrombin release and suggest that the brain microcirculation could be a source of neurotoxic factors in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201482     DOI: 10.3233/jad-2004-6308

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease.

Authors:  John Gunstad; Linda Bausserman; Robert H Paul; David F Tate; Karin Hoth; Athena Poppas; Angela L Jefferson; Ronald A Cohen
Journal:  J Clin Neurosci       Date:  2006-05-24       Impact factor: 1.961

Review 3.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

Review 4.  Natural secretory products of human neural and microvessel endothelial cells: Implications in pathogenic "spreading" and Alzheimer's disease.

Authors:  Yuhai Zhao; Jian-Guo Cui; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

5.  Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease.

Authors:  Xiangling Yin; Jill Wright; Trevor Wall; Paula Grammas
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

6.  Thrombin activity associated with neuronal damage during acute focal ischemia.

Authors:  Bo Chen; Beth Friedman; Michael A Whitney; Jessica A Van Winkle; I-Farn Lei; Emilia S Olson; Qun Cheng; Benedict Pereira; Lifu Zhao; Roger Y Tsien; Patrick D Lyden
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

7.  Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Authors:  Lakshmi Thirumangalakudi; Haripriya Vittal Rao; Paula Grammas
Journal:  Neurosci Lett       Date:  2009-01-21       Impact factor: 3.046

Review 8.  Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.

Authors:  Paula Grammas
Journal:  J Neuroinflammation       Date:  2011-03-25       Impact factor: 8.322

9.  Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model.

Authors:  Takashi Machida; Fuyuko Takata; Junichi Matsumoto; Tomoyuki Miyamura; Ryosuke Hirata; Ikuya Kimura; Yasufumi Kataoka; Shinya Dohgu; Atsushi Yamauchi
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

10.  Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.

Authors:  Alex E Roher; David H Cribbs; Ronald C Kim; Chera L Maarouf; Charisse M Whiteside; Tyler A Kokjohn; Ian D Daugs; Elizabeth Head; Carolyn Liebsack; Geidy Serrano; Christine Belden; Marwan N Sabbagh; Thomas G Beach
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.